7th Annual Retinal Cell and Gene Therapy Innovation Summit
Friday, May 1st, 2020, 7:00 AM
101 W Fayette Street
Baltimore, MD 21201
Representatives from biotech and pharma industries come together with physicians and scientists to discuss rapidly emerging ocular gene and cell therapies and strategize how to move the most advanced retinal disease therapy options forward.
The summit features presentations by leading retinal disease experts on potential gene and stem-cell therapies and how best to deliver them to patients. In this intimate, congenial setting, summit attendees discuss progress being made in the field and how to use initial successes to move toward larger scale trials. Seating is limited to 350 attendees.